The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load
Open accessAbstract
BACKGROUND: Few data are available regarding the use of tenofovir disoproxil fumarate (TDF) during pregnancy for the prevention of mother-to-child transmission of hepatitis B virus (HBV). METHODS: In this trial, we included 200 mothers who were positive for hepatitis B e antigen (HBeAg) and who had an HBV DNA level higher than 200,000 IU per milliliter. Participants were randomly assigned, in a 1:1 ratio, to receive usual care without antiviral therapy or to receive TDF (at an oral dose of 300 mg per day) from 30 to 32 weeks of gestation until postpartum week 4; the participants were followed until postpartum week 28. All the infants received immunoprophylaxis. The primary outcomes were the rates of mother-to-child transmission and birth defects. The secondary outcomes were the safety of TDF, the percentage of mothers with an HBV DNA level of less than 200,000 IU per milliliter at delivery, and loss or seroconversion of HBeAg or hepatitis B surface antigen at postpartum week 28. RESULTS: At delivery, 68% of the mothers in the TDF group (66 of 97 women), as compared with 2% in the control group (2 of 100), had an HBV DNA level of less than 200,000 IU per milliliter (P<0.001). At postpartum week 28, the rate of mother-to-child transmission was significantly lower in the TDF group than in the control group, both in the intention-to-treat analysis (with transmission of virus to 5% of the infants [5 of 97] vs. 18% [18 of 100], P=0.007) and the per-protocol analysis (with transmission of virus to 0 vs. 7% [6 of 88], P=0.01). The maternal and infant safety profiles were similar in the TDF group and the control group, including birth-defect rates (2% [2 of 95 infants] and 1% [1 of 88], respectively; P=1.00), although more mothers in the TDF group had an increase in the creatine kinase level. After the discontinuation of TDF, alanine aminotransferase elevations above the normal range occurred more frequently in mothers in the TDF group than in those in the control group (45% [44 of 97 women] vs. 30% [30 of 100], P=0.03). The maternal HBV serologic outcomes did not differ significantly between the groups. CONCLUSIONS: In a cohort of HBeAg-positive mothers with an HBV DNA level of more than 200,000 IU per milliliter during the third trimester, the rate of mother-to-child transmission was lower among those who received TDF therapy than among those who received usual care without antiviral therapy. (Funded by Gilead Sciences; ClinicalTrials.gov number, NCT01488526.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Methods for Rates and Proportions
Fleiss, J. L., Levin, B., & Paik, M. C. (2003) · Wiley Series in Probability and Statistics · doi:10.1002/0471445428 · Cited by 18,646
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
European Association for the Study of the Liver (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.010 · Cited by 2,925
Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B
Marcellin, P., Heathcote, E. J., Buti, M., Gane, E., de Man, R. A., Krastev, Z., Germanidis, G., Lee, S. S., Flisiak, R., Kaita, K., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802878 · Cited by 1,181
Vertical Transmission of Hepatitis B Antigen in Taiwan
Stevens, C. E., Beasley, R. P., Tsui, J., & Lee, W.-C. (1975) · New England Journal of Medicine · doi:10.1056/nejm197504102921503 · Cited by 1,022
(2005) · PsycEXTRA Dataset · doi:10.1037/e548682006-001 · Cited by 753
THE e ANTIGEN AND VERTICAL TRANSMISSION OF HEPATITIS B SURFACE ANTIGEN
BEASLEY, R. P., TREPO, C., STEVENS, C. E., & SZMUNESS, W. (1977) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112370 · Cited by 611
Keeffe, E. B., Dieterich, D. T., Han, S.-H. B., Jacobson, I. M., Martin, P., Schiff, E. R., & Tobias, H. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.08.021 · Cited by 558
Xu, W. ‐., Cui, Y. ‐., Wang, L., Yang, H., Liang, Z. ‐., Li, X. ‐., Zhang, S. ‐., Qiao, F. ‐., Campbell, F., Chang, C. ‐., et al. (2009) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2008.01056.x · Cited by 387
Self-citationPerinatal transmission of hepatitis B virus: an Australian experience
Wiseman, E., Fraser, M. A., Holden, S., Glass, A., Kidson, B. L., Heron, L. G., Maley, M. W., Ayres, A., LOCARNINI, S. A., & Levy, M. T. (2009) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2009.tb02524.x · Cited by 378
Zou, H., Chen, Y., Duan, Z., Zhang, H., & Pan, C. (2012) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2011.01492.x · Cited by 366
Self-citationHan, G.-R., Cao, M.-K., Zhao, W., Jiang, H.-X., Wang, C.-M., Bai, S.-F., Yue, X., Wang, G.-J., Tang, X., & Fang, Z.-X. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.02.032 · Cited by 363
Self-citationPan, C. Q., Duan, Z., Bhamidimarri, K. R., Zou, H., Liang, X., Li, J., & Tong, M. J. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.10.041 · Cited by 265
Self-citationChen, H., Lee, C., Chang, C., Ni, Y., Shyu, M., Chen, S., Hu, J., Lin, H. H., Zhao, L., Mu, S., et al. (2015) · Hepatology · doi:10.1002/hep.27837 · Cited by 255
Zhang, H., Pan, C. Q., Pang, Q., Tian, R., Yan, M., & Liu, X. (2014) · Hepatology · doi:10.1002/hep.27034 · Cited by 199
Self-citationNatural History and Clinical Consequences of Hepatitis B Virus Infection
Pan, C. Q., & Zhang, J. X. (2005) · International Journal of Medical Sciences · doi:10.7150/ijms.2.36 · Cited by 197
Self-citationHepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers
Lee, C., Gong, Y., Brok, J., Boxall, E. H., & Gluud, C. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004790.pub2 · Cited by 184
Greenup, A.-J., Tan, P. K., Nguyen, V., Glass, A., Davison, S., Chatterjee, U., Holdaway, S., Samarasinghe, D., Jackson, K., Locarnini, S. A., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.04.038 · Cited by 167
Telbivudine Prevents Vertical Transmission From HBeAg-Positive Women With Chronic Hepatitis B
Pan, C. Q., Han, G., Jiang, H., Zhao, W., Cao, M., Wang, C., Yue, X., & Wang, G. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.01.019 · Cited by 152
Self-citationBenaboud, S., Pruvost, A., Coffie, P. A., Ekouévi, D. K., Urien, S., Arrivé, É., Blanche, S., Théodoro, F., Avit, D., Dabis, F., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00514-10 · Cited by 137
Pan, C. Q., Mi, L.-J., Bunchorntavakul, C., Karsdon, J., Huang, W. M., Singhvi, G., Ghany, M. G., & Reddy, K. R. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2187-3 · Cited by 119
Self-citationdel Canho, R., Grosheide, P. M., Schalm, S. W., de Vries, R. R. P., & Heijtink, R. A. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80494-5 · Cited by 109
TRANSMISSION OF HEPATITIS B ANTIGENS FROM SYMPTOM FREE CARRIER MOTHERS TO THE FETUS AND THE INFANT
WONG, V. C. W., Lee, A. K. Y., & Ip, H. M. H. (1980) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1980.tb04458.x · Cited by 101
Antiviral Therapy for Chronic Hepatitis B in Pregnancy
Lee, H. M., & Pan, C. Q. (2013) · Seminars in Liver Disease · doi:10.1055/s-0033-1345718 · Cited by 74
Self-citationPerumalswami, P., Factor, S. H., Kapelusznik, L., Friedman, S. L., Pan, C. Q., Chang, C., Clemente, F. D., & Dieterich, D. T. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.01.004 · Cited by 64
Self-citationWu, Q., Huang, H., Sun, X., Pan, M., He, Y., Tan, S., Zeng, Y., Li, L., Deng, G., Yan, Z., et al. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.08.043 · Cited by 60
Self-citationPan, C. Q., Trinh, H. N., Yao, A., Bae, H., Lou, L., Chan, S., & for the Study 123 Group (2014) · PLoS ONE · doi:10.1371/journal.pone.0089789 · Cited by 24
Self-citation
Cited by
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
Lampertico, P., Agarwal, K., Berg, T., Buti, M., Janssen, H. L. A., Papatheodoridis, G., Zoulim, F., & Tacke, F. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.021 · Cited by 5,391
Terrault, N. A., Lok, A. S. F., McMahon, B. J., Chang, K., Hwang, J. P., Jonas, M. M., Brown, R. S., Bzowej, N. H., & Wong, J. B. (2018) · Hepatology · doi:10.1002/hep.29800 · Cited by 4,306
Yuen, M.-F., Chen, D.-S., Dusheiko, G. M., Janssen, H. L. A., Lau, D. T. Y., Locarnini, S. A., Peters, M. G., & Lai, C.-L. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.35 · Cited by 814
Chronic Hepatitis B Infection: A Review
Tang, L. S. Y., Covert, E., Wilson, E., & Kottilil, S. (2018) · JAMA · doi:10.1001/jama.2018.3795 · Cited by 657
Global burden of hepatitis B virus: current status, missed opportunities and a call for action
Hsu, Y.-C., Huang, D. Q., & Nguyen, M. H. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00760-9 · Cited by 632
Metadata
- Authors
- Pan, C. Q., Duan, Z., Dai, E., Zhang, S., Han, G., Wang, Y., Zhang, H., Zou, H., Zhu, B., Zhao, W., & Jiang, H.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2016-06-16
- Volume
- 374
- Issue
- 24
- Pages
- 2324-2334
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2442031947
- Cited by
- 573
- References
- 26
- FWCI
- 63.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.